Format
Sort by

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 101

1.

Decline in Cardiovascular Mortality: Possible Causes and Implications.

Mensah GA, Wei GS, Sorlie PD, Fine LJ, Rosenberg Y, Kaufmann PG, Mussolino ME, Hsu LL, Addou E, Engelgau MM, Gordon D.

Circ Res. 2017 Jan 20;120(2):366-380. doi: 10.1161/CIRCRESAHA.116.309115. Review.

PMID:
28104770
2.

Building on a Legacy of Hypertension Research: Charting Our Future Together.

Mensah GA, Galis ZS, Fine LJ, Garcia ME, Levy DF, Gibbons GH.

Hypertension. 2017 Jan;69(1):5-10. No abstract available.

PMID:
27849567
3.

Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study.

Drawz PE, Pajewski NM, Bates JT, Bello NA, Cushman WC, Dwyer JP, Fine LJ, Goff DC Jr, Haley WE, Krousel-Wood M, McWilliams A, Rifkin DE, Slinin Y, Taylor A, Townsend R, Wall B, Wright JT, Rahman M.

Hypertension. 2017 Jan;69(1):42-50.

PMID:
27849563
4.

Comparing the SPRINT and the HOPE-3 Blood Pressure Trial.

Whelton PK, Reboussin DM, Fine LJ.

JAMA Cardiol. 2016 Nov 1;1(8):855-856. doi: 10.1001/jamacardio.2016.2051. No abstract available.

PMID:
27604076
5.

SPRINT and Implications for Target Organ Protection in African Americans.

Wright JT, Fine LJ.

Ethn Dis. 2016 Jul 21;26(3):271-4. doi: 10.18865/ed.26.3.271. No abstract available.

PMID:
27440964
6.

Intensive vs Standard Blood Pressure Control and Cardiovascular Disease Outcomes in Adults Aged ≥75 Years: A Randomized Clinical Trial.

Williamson JD, Supiano MA, Applegate WB, Berlowitz DR, Campbell RC, Chertow GM, Fine LJ, Haley WE, Hawfield AT, Ix JH, Kitzman DW, Kostis JB, Krousel-Wood MA, Launer LJ, Oparil S, Rodriguez CJ, Roumie CL, Shorr RI, Sink KM, Wadley VG, Whelton PK, Whittle J, Woolard NF, Wright JT Jr, Pajewski NM; SPRINT Research Group..

JAMA. 2016 Jun 28;315(24):2673-82. doi: 10.1001/jama.2016.7050.

7.

The Productivity of NHLBI-Funded Obesity Research, 1983-2013.

Nicastro HL, Belter CW, Lauer MS, Coady SA, Fine LJ, Loria CM.

Obesity (Silver Spring). 2016 Jun;24(6):1356-65. doi: 10.1002/oby.21478.

PMID:
27145059
8.

SPRINT Trial Results: Latest News in Hypertension Management.

Cushman WC, Whelton PK, Fine LJ, Wright JT Jr, Reboussin DM, Johnson KC, Oparil S; SPRINT Study Research Group..

Hypertension. 2016 Feb;67(2):263-5. doi: 10.1161/HYPERTENSIONAHA.115.06722. Review. No abstract available.

PMID:
26553234
9.

A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

SPRINT Research Group., Wright JT Jr, Williamson JD, Whelton PK, Snyder JK, Sink KM, Rocco MV, Reboussin DM, Rahman M, Oparil S, Lewis CE, Kimmel PL, Johnson KC, Goff DC Jr, Fine LJ, Cutler JA, Cushman WC, Cheung AK, Ambrosius WT.

N Engl J Med. 2015 Nov 26;373(22):2103-16. doi: 10.1056/NEJMoa1511939.

10.

The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).

Ambrosius WT, Sink KM, Foy CG, Berlowitz DR, Cheung AK, Cushman WC, Fine LJ, Goff DC Jr, Johnson KC, Killeen AA, Lewis CE, Oparil S, Reboussin DM, Rocco MV, Snyder JK, Williamson JD, Wright JT Jr, Whelton PK; SPRINT Study Research Group..

Clin Trials. 2014 Oct;11(5):532-46. doi: 10.1177/1740774514537404.

11.

Effect of long-chain ω-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial.

Writing Group for the AREDS2 Research Group., Bonds DE, Harrington M, Worrall BB, Bertoni AG, Eaton CB, Hsia J, Robinson J, Clemons TE, Fine LJ, Chew EY.

JAMA Intern Med. 2014 May;174(5):763-71. doi: 10.1001/jamainternmed.2014.328.

PMID:
24638908
12.

Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association.

Olin JW, Gornik HL, Bacharach JM, Biller J, Fine LJ, Gray BH, Gray WA, Gupta R, Hamburg NM, Katzen BT, Lookstein RA, Lumsden AB, Newburger JW, Rundek T, Sperati CJ, Stanley JC; American Heart Association Council on Peripheral Vascular Disease.; American Heart Association Council on Clinical Cardiology.; American Heart Association Council on Cardiopulmonary, Critical Care, Perioperative and Resuscitation.; American Heart Association Council on Cardiovascular Disease in the Young.; American Heart Association Council on Cardiovascular Radiology and Intervention.; American Heart Association Council on Epidemiology and Prevention.; American Heart Association Council on Functional Genomics and Translational Biology.; American Heart Association Council for High Blood Pressure Research.; American Heart Association Council on the Kidney in Cardiovascular Disease.; American Heart Association Stroke Council..

Circulation. 2014 Mar 4;129(9):1048-78. doi: 10.1161/01.cir.0000442577.96802.8c. No abstract available.

13.

Evidence supporting a systolic blood pressure goal of less than 150 mm Hg in patients aged 60 years or older: the minority view.

Wright JT Jr, Fine LJ, Lackland DT, Ogedegbe G, Dennison Himmelfarb CR.

Ann Intern Med. 2014 Apr 1;160(7):499-503. doi: 10.7326/M13-2981. No abstract available.

PMID:
24424788
14.

Centers for cardiovascular outcomes research: defining a collaborative vision.

Cook NL, Bonds DE, Kiefe CI, Curtis JP, Krumholz HM, Kressin NR, Peterson ED; National Heart, Lung, and Blood Institute Centers for Cardiovascular Research (CCOR) Writing Group..

Circ Cardiovasc Qual Outcomes. 2013 Mar 1;6(2):223-8. doi: 10.1161/CIRCOUTCOMES.0b013e31828e8d5c.

15.

Depression predicts all-cause mortality: epidemiological evaluation from the ACCORD HRQL substudy.

Sullivan MD, O'Connor P, Feeney P, Hire D, Simmons DL, Raisch DW, Fine LJ, Narayan KM, Ali MK, Katon WJ.

Diabetes Care. 2012 Aug;35(8):1708-15. doi: 10.2337/dc11-1791.

16.

Long-term renal and cardiovascular outcomes in Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) participants by baseline estimated GFR.

Rahman M, Ford CE, Cutler JA, Davis BR, Piller LB, Whelton PK, Wright JT Jr, Barzilay JI, Brown CD, Colon PJ Sr, Fine LJ, Grimm RH Jr, Gupta AK, Baimbridge C, Haywood LJ, Henriquez MA, Ilamaythi E, Oparil S, Preston R; ALLHAT Collaborative Research Group..

Clin J Am Soc Nephrol. 2012 Jun;7(6):989-1002. doi: 10.2215/CJN.07800811.

17.

Relationships between changes in patient-reported health status and functional capacity in outpatients with heart failure.

Flynn KE, Lin L, Moe GW, Howlett JG, Fine LJ, Spertus JA, McConnell TR, Piña IL, Weinfurt KP.

Am Heart J. 2012 Jan;163(1):88-94.e3. doi: 10.1016/j.ahj.2011.09.027.

18.

Factors related to morbidity and mortality in patients with chronic heart failure with systolic dysfunction: the HF-ACTION predictive risk score model.

O'Connor CM, Whellan DJ, Wojdyla D, Leifer E, Clare RM, Ellis SJ, Fine LJ, Fleg JL, Zannad F, Keteyian SJ, Kitzman DW, Kraus WE, Rendall D, Piña IL, Cooper LS, Fiuzat M, Lee KL.

Circ Heart Fail. 2012 Jan;5(1):63-71. doi: 10.1161/CIRCHEARTFAILURE.111.963462.

19.

Relation among body mass index, exercise training, and outcomes in chronic systolic heart failure.

Horwich TB, Broderick S, Chen L, McCullough PA, Strzelczyk T, Kitzman DW, Fletcher G, Safford RE, Ewald G, Fine LJ, Ellis SJ, Fonarow GC.

Am J Cardiol. 2011 Dec 15;108(12):1754-9. doi: 10.1016/j.amjcard.2011.07.051.

20.

Effects of medical therapies on retinopathy progression in type 2 diabetes.

ACCORD Study Group.; ACCORD Eye Study Group., Chew EY, Ambrosius WT, Davis MD, Danis RP, Gangaputra S, Greven CM, Hubbard L, Esser BA, Lovato JF, Perdue LH, Goff DC Jr, Cushman WC, Ginsberg HN, Elam MB, Genuth S, Gerstein HC, Schubart U, Fine LJ.

N Engl J Med. 2010 Jul 15;363(3):233-44. doi: 10.1056/NEJMoa1001288. Erratum in: N Engl J Med. 2011 Jan 13;364(2):190. N Engl J Med. 2012 Dec 20;367(25):2458.

Items per page

Supplemental Content

Loading ...
Support Center